Cost-savings and health impact of strategies for prevention of Respiratory Syncytial Virus with nirsevimab in Chile based on the integrated analysis of 2019–2023 national databases: A retrospective study

Related documents

• Epidemiología del trauma de alta energía en Chile: análisis ecológico con registros públicos#928276
• Beyond tobacco: genomic disparities in lung cancer between smokers and never-smokers#928277
• NorDark-DT: A digital twin for urban lighting infrastructure planning and analysis#928278
• Impact of the chemical modification of tRNAs anticodon loop on the variability and evolution of codon usage in proteobacteria#928279
• Host Galaxies for Four Nearby CHIME/FRB Sources and the Local Universe FRB Host Galaxy Population#928280